TABLE 4.

Facial erythema from baseline to Week 16 with E-BPO versus vehicle cream: Percent of patients achieving no or mild erythema

TIME POINT	TREATMENT 1-2 (n=15)	TREATMENT 2-1 (n=16)
Baseline	0	0
Week 2	71.43	25.00
Week 4	71.43	25.00
Week 8	85.71	43.75
Week 12	85.71	80.00
Week 16	78.57	78.57
Range	21.43–85.71	25.00–80.00

E-BPO: microencapsulated benzoyl peroxide cream, 5%; IGA: Investigator Global Assessment